Cipla Q4 FY26 Net Profit Declines 55% YoY

Cipla reported Q4 FY26 consolidated PAT of ₹555 Cr, down 55% YoY, with an EBITDA margin of 15.2%.
Annual revenue reached a record ₹28,163 Cr, driven by 9% growth in One-India business which surpassed ₹12,680 Cr.
The company received USFDA approval for first AB-rated gVentolin and recommended a final dividend of ₹13 per share.